Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Public Service Company of New Mexico Declares Preferred Dividend
-
Cerence Names Tony Rodriquez as Interim Chief Financial Officer
-
EOG Resources to Present at Upcoming Conference
-
AEO Inc. Declares a Regular Quarterly Dividend of $0.125 Per Share
-
Kinetik Completes Divestiture of Its Equity Interest in Gulf Coast Express Pipeline
-
The Hartford Appoints Kathleen Winters To Its Board Of Directors
-
Hardscape.com Joins SiteOne Landscape Supply
-
HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer
-
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
HeartSciences Regains Compliance with Nasdaq Listing Requirements
-
Graphjet Technology Receives Notification of Delinquency from Nasdaq
-
CEA Industries Inc. Announces Reverse Stock Split to be Effective June 7, 2024; Publicly Traded Warrant Adjustment
-
3D Systems Provides Important Update on Dental Growth Strategy
-
Gaming Innovation Group - Mandatory notification of trade
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Toyota Motor Corporation Investors to Inquire About Securities Class Action Investigation – TM
-
Blackwell 3D Launches Philippines Subsidiary to Drive Affordable Housing Solutions
-
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
-
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Herc Holdings Announces Pricing of Upsized $800 Million Senior Unsecured Notes Offering
-
KB Home to Release 2024 Second Quarter Earnings on June 18, 2024
-
ASPCA Encourages Public to Be Part of the "Rescue Effect" By Adopting and Fostering Shelter Animals During Adopt a Shelter Cat Month in June
-
PennantPark Floating Rate Capital Ltd. Upsizes Credit Facility to $611 Million
-
Modernizing Higher Education: Info-Tech Research Group Identifies Four Exponential IT Priorities to Improving Academic Delivery
-
Nasdaq May 2024 Volumes
-
Stitch Fix Announces Third Quarter of Fiscal Year 2024 Financial Results
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
Hewlett Packard Enterprise Reports Fiscal 2024 Second Quarter Results
-
CrowdStrike Reports First Quarter Fiscal Year 2025 Financial Results
-
Verint Announces Strong Q1 FYE 2025 Results
-
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market initiatives
-
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
-
PagerDuty Announces Integration with Snowflake Trail to Improve Observability Workflows
-
EZCORP to Participate in June Conferences
-
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
-
Skechers to Present at the Evercore ISI Consumer and Retail Conference on June 11th
-
Oracle Sets the Date for its Fourth Quarter Fiscal Year 2024 Earnings Announcement
-
Intel and Apollo Agree to Joint Venture Related to Intel’s Fab 34 in Ireland
-
Rogers Corporation to Participate in Upcoming Investor Conferences
-
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
-
Purple to Participate in Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
-
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (Nasdaq:BPTH) Q1 24
-
Myers Industries Announces Quarterly Dividend
-
Nextracker to Present at the J.P. Morgan Energy, Power & Renewables Conference
-
Root, Inc. to Participate in the TD Financial Services & Fintech Summit
-
Allison Transmission Announces G. Frederick Bohley as New Chief Operating Officer
-
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja California Desalination Project
-
Agilysys to Participate in Baird 2024 Global Consumer, Technology & Services Conference
-
RGP Appoints Roger Carlile to Its Board of Directors
-
ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
-
Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer
